MARKET

VIR

VIR

Vir Biotechnology, Inc.
NASDAQ
4.510
-0.220
-4.65%
After Hours: 4.520 +0.01 +0.22% 18:25 05/21 EDT
OPEN
4.640
PREV CLOSE
4.730
HIGH
4.740
LOW
4.405
VOLUME
1.51M
TURNOVER
--
52 WEEK HIGH
14.45
52 WEEK LOW
4.320
MARKET CAP
623.45M
P/E (TTM)
-1.0677
1D
5D
1M
3M
1Y
5Y
1D
Vir Biotechnology to Participate in TD Cowen 6th Annual Oncology Innovation Summit
Barchart · 1d ago
Vir Biotechnology price target lowered to $15 from $110 at H.C. Wainwright
TipRanks · 1d ago
VIR BIOTECHNOLOGY, INC. <VIR.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $15 FROM $110
Reuters · 1d ago
Weekly Report: what happened at VIR last week (0512-0516)?
Weekly Report · 2d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Vir Biotechnology (VIR) and Belite Bio, Inc. ADR (BLTE)
TipRanks · 6d ago
Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference
Barchart · 05/12 15:05
Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga · 05/12 13:46
Vir Biotechnology Is Maintained at Buy by Needham
Dow Jones · 05/12 13:15
More
About VIR
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. It also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Tobevibart is an investigational neutralizing monoclonal antibody (mAb) that has been engineered for immune engagement and targets a conserved region on the hepatitis B surface antigen (HBsAg). Elebsiran is an investigational HBV-targeted small interfering RNA (siRNA) that reduces HBsAg. Its pipeline includes VIR-5818, VIR-5500, VIR-5525, and HIV Cure. It also has rights to the PRO-XTEN masking platform for oncology and infectious disease.

Webull offers Vir Biotechnology Inc stock information, including NASDAQ: VIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VIR stock methods without spending real money on the virtual paper trading platform.